Patents by Inventor Eric McFee Parker

Eric McFee Parker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7560449
    Abstract: The present invention provides methods for treating demyelination and associated conditions by administering at least one sterol absorption inhibitor and compositions, therapeutic combinations and methods including: (a) at least one sterol absorption inhibitor; and (b) at least one demyelination treatment which can be useful for preventing or treating demyelination and associated conditions, such as multiple sclerosis.
    Type: Grant
    Filed: November 4, 2003
    Date of Patent: July 14, 2009
    Assignee: Schering Corporation
    Inventors: Jay S. Fine, Eric McFee Parker
  • Publication number: 20080166318
    Abstract: The present invention provides methods for treating demyelination and associated conditions by administering at least one sterol absorption inhibitor and compositions, therapeutic combinations and methods including: (a) at least one sterol absorption inhibitor; and (b) at least one demyelination treatment which can be useful for preventing or treating demyelination and associated conditions, such as multiple sclerosis.
    Type: Application
    Filed: March 5, 2008
    Publication date: July 10, 2008
    Inventors: Jay S. Fine, Eric McFee Parker
  • Publication number: 20040092500
    Abstract: The present invention provides methods for treating demyelination and associated conditions by administering at least one sterol absorption inhibitor and compositions, therapeutic combinations and methods including: (a) at least one sterol absorption inhibitor; and (b) at least one demyelination treatment which can be useful for preventing or treating demyelination and associated conditions, such as multiple sclerosis.
    Type: Application
    Filed: November 4, 2003
    Publication date: May 13, 2004
    Applicant: Schering Corporation
    Inventors: Jay S. Fine, Eric McFee Parker
  • Publication number: 20030013699
    Abstract: Methods of preventing, treating, or ameliorating symptoms of Alzheimer's Disease, regulating production or levels of amyloid &bgr; (A&bgr;) peptides and/or regulating the amount of ApoE isoform 4 in the bloodstream and/or brain are provided which include the step of administering to a subject in need of such treatment an effective amount of a composition including at least one compound represented by Formulae (I-X) disclosed herein.
    Type: Application
    Filed: May 22, 2002
    Publication date: January 16, 2003
    Inventors: Harry R. Davis, Eric McFee Parker, Margaret van Heek, Gwendolyn T. Wong, Laura B. Merkel
  • Patent number: 5985616
    Abstract: The present invention provides mammalian chimeric NPY Y.sub.5 receptors, nucleic acids and vectors encoding the receptors, methods for making the receptors, fragments or fusion proteins thereof using recombinant DNA methodology or chemical synthesis, and methods for using the receptors in screening systems to identify compounds for the treatment of various diseases.
    Type: Grant
    Filed: January 7, 1998
    Date of Patent: November 16, 1999
    Assignee: Schering Corporation
    Inventors: Eric McFee Parker, Catherine Devine Strader, Mark Stephen Rudinski